Jiangsu Recbio Shoots to Become Hong Kong’s First HPV Vaccine Stock
The vaccine producer is making a second attempt to list in Hong Kong, as its core HPV vaccine undergoes Phase 3 clinical trials Key takeaways: Jiangsu Recbio has filed a…
New Horizon Health Gets Booster with New Product Approval
Company says its UU Tube used to self-screen for stomach cancer has been approved by China’s health regulator Key takeaways: New Horizon Health says its first-of-its-kind UU Tube self-screening product…